JNCCN 360

Editors:

Daniel G. Coit, MD

Michael A. Postow, MD

Advertisement

Advertisement

Ongoing CE Activities

A Multidisciplinary Approach to Individualized Patient Care - Melanoma

Approaches for Early Diagnosis, Risk Stratification, and Multidisciplinary Management of Stage I/II Melanoma

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Melanoma

Optimizing Treatment for Patients With BRAF V600 Mutation–Positive Metastatic Melanoma

BRAF/MEK Inhibitor Combo Produces Benefits in Advanced Melanoma

Dermatologic Oncology Update: Conversations with Oncology Investigators Bridging the Gap between Research and Patient Care

Dermatologic Oncology Update, Issue 1, 2018

NCCN Pharmacy Updates: New and Emerging Treatment Options for Melanoma

From IDO to IDON'T: Lessons Learned After a Combo Fails in Advanced Melanoma

Management of Melanoma

Metastatic Melanoma: What Would You Do?

Oncology Today with Dr. Neil Love, Melanoma Edition: Case Study

Oncology Today with Dr. Neil Love, Melanoma Edition: Evolving Adjuvant Treatment Approaches for Patients With Localized Melanoma

The Evolving Role of Biomarkers in Oncology

The Nurse View: What Do You Need to Know About Immune Checkpoint Inhibitors?

NCCN Pharmacy Updates: Treatment Considerations in Metastatic Melanoma

Tumor Mutation Burden Testing

Understanding the Role of Targets and Pathways in the Treatment of Melanoma

Sections

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.